advances in adjuvant and 1l immune checkpoint blockade for gastric and esophageal cancer
Published 2 years ago • 174 plays • Length 4:29Download video MP4
Download video MP3
Similar videos
-
5:00
surgical advances in in gastric and gej cancer
-
1:13
unmet needs in advanced esophageal cancer
-
1:31:24
checkpoint inhibition in gi cancers: recent advances in gastric, esophageal, and crc
-
20:21
check-point inhibitors in esophageal and gastric cancer: when and for whom?
-
1:28
advances in biomarker-directed therapies for gastric cancer
-
4:59
checkmate 648: 1l io-io in advanced esophageal squamous cell carcinoma
-
2:25
adjuvant therapy for esophageal cancer
-
59:11
immune checkpoint inhibitor therapy for locally advanced and early-stage esophageal/gej cancer
-
1:50
durvalumab and pet-directed chemoradiation in advanced esophageal cancer
-
1:25
pd-1 and pd-l1 expression in esophageal and gastric cancer
-
10:44
earlier use of immune checkpoint inhibitors to adjuvant and non muscle invasive bladder cancer
-
1:04:22
immunotherapy management of early and advanced gastric, esophageal, gej, and colorectal cancers
-
21:34
new evolutions for the neo-adjuvant and adjuvant treatment of esophageal cancer
-
1:58
who benefits from immunotherapy in patients with advanced escc?
-
2:09
recent advances in gastrointestinal research: destiny-gastric01 and spotlight
-
0:48
current and future directions in gastric cancer research
-
43:05
treatment of esophageal cancer in 2021 | zev a. wainberg, md | professor of medicine, ucla
-
13:56
emerging data with immunotherapy in esophageal squamous cell carcinoma
-
1:31
highlights and key clinical trial updates from asco gi 2022